WIC
AGN

Woodmont Investment Counsel’s Allergan plc AGN Stock Holding History

Woodmont Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-31
Closed -$7K – 689
2016
Q3 		$7K Buy
+31
New +$7.58K ﹤0.01% 525
2016
Q2 		– Sell
-118
Closed -$32K – 498
2016
Q1 		$32K Sell
118
-82
-41% -$23.5K 0.01% 309
2015
Q4 		$63K Buy
+200
New +$59.5K 0.02% 247

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Woodmont Investment Counsel's AGN Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 31 shares — an estimated $7K sold.

Woodmont Investment Counsel first reported a position in AGN in Q4 2015 and held it in 3 quarters. The position peaked at $63K in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 31 Allergan plc shares in Q4 2016, an estimated $7K.
  • Woodmont Investment Counsel first reported a position in Allergan plc in Q4 2015 and held it in 3 quarters.
  • Woodmont Investment Counsel's Allergan plc position peaked at $63K in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.